Question follow-through · 83025
Prostate Cancer: Screening
To ask the Secretary of State for Health and Social Care, whether his Department plans to publish the geographical distribution of sites involved in the TRANSFORM trial; and what criteria were used to select them.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 17 Oct 2025
- Target answer date
- 21 Oct 2025
- Answer
- 27 Oct 2025 · 10 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Liver Cancer: Diagnosis · 26 Mar 2026
- Liver Cancer · 26 Mar 2026
- Leukaemia: Diagnosis · 22 Apr 2026
- Phlebotomy: Staff · 26 Jun 2026
- Sodium Valproate and Surgical Mesh Implants: Compensation · 2 Jul 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
17 Oct 2025
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department plans to publish the geographical distribution of sites involved in the TRANSFORM trial; and what criteria were used to select them.
21 Oct 2025
Target answer date
Date supplied by the official written-questions record.
27 Oct 2025
Answer published
The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR).In November 2023, the Government and Prostate Cancer UK (PCUK) announced the £42 million TRANSFORM...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Liver Cancer: Diagnosis
26 Mar 2026 · To ask the Secretary of State for Health and Social Care, what estimate the Department has made of waiting times for diagnostic imaging for suspected liver cancer; and what steps it is taking to reduce waiting times in diagnosis.
Liver Cancer
26 Mar 2026 · To ask the Secretary of State for Health and Social Care, what assessment the Department has made of variation in liver cancer survival outcomes between integrated care systems; and what steps it is taking to reduce that variation.
Leukaemia: Diagnosis
22 Apr 2026 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of reducing the rate of emergency diagnosis on five-year survival rates for patients with acute myeloid leukaemia.
Phlebotomy: Staff
26 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of phlebotomy workforce shortages on access to urgent Full Blood Count testing.
Sodium Valproate and Surgical Mesh Implants: Compensation
2 Jul 2026 · To ask the Secretary of State for Health and Social Care, what progress his Department has made in considering options for redress for patients affected by valproate and pelvic mesh, and when he expects to set out next steps in response to the Hughes Repo